Bariatric Surgery and Prevention of Type 2 Diabetes in Swedish Obese Subjects
Lena Carlsson(University of Gothenburg), Lars Sjöström(Sahlgrenska University Hospital), Kajsa Sjöholm(University of Gothenburg), Stefano Romeo(Sahlgrenska University Hospital), Elisabeth Stoltz Sjöström(University of Gothenburg), Hans Lönroth, Björn Carlsson, Ingmar Näslund(Örebro University Hospital), Per‐Arne Svensson(University of Gothenburg), Sofie Ahlin, Claude Bouchard(Pennington Biomedical Research Center), Cristina Maglio(Sahlgrenska University Hospital), Markku Peltonen(Finnish Institute for Health and Welfare), Åsa Anveden, Peter Jacobson(University of Michigan), Carlo Pirazzi, Hans Wedel(Sahlgrenska University Hospital)
Cited by 788
Related Papers
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
|New England Journal of Medicine|2004|4.5k